|BBH -- USA Etf|| |
USD 127.68 1.56 0.01%
The entity has beta of 0.0027 which indicates as returns on market increase, VanEck Vectors returns are expected to increase less than the market. However during bear market, the loss on holding VanEck Vectors will be expected to be smaller as well. Although it is extremely important to respect VanEck Vectors Biotech
current price movements, it is better to be realistic regarding the information on equity historical returns. The philosophy towards measuring future performance of any etf is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators
. By inspecting VanEck Vectors Biotech technical indicators
you can presently evaluate if the expected return of 0.2345% will be sustainable into the future.
VanEck Vectors Biotech Relative Risk vs. Return Landscape
If you would invest 11,700
in VanEck Vectors Biotech ETF on December 22, 2018
and sell it today you would earn a total of 1,068
from holding VanEck Vectors Biotech ETF or generate 9.13%
return on investment over 30
days. VanEck Vectors Biotech ETF is generating 0.2345% of daily returns assuming volatility of 2.1019% on return distribution over 30 days investment horizon. In other words, 19% of equities are less volatile than the company and above 96% of equities are expected to generate higher returns over the next 30 days.
Daily Expected Return (%)
Considering 30-days investment horizon, VanEck Vectors is expected to generate 1.04 times more return on investment than the market. However, the company is 1.04 times more volatile than its market benchmark. It trades about 0.11 of its potential returns per unit of risk. The DOW is currently generating roughly 0.03 per unit of risk.
VanEck Vectors Market Risk Analysis
Sharpe Ratio = 0.1116
VanEck Vectors Relative Performance Indicators
Estimated Market Risk
| || |
| || |
| || |
Based on monthly moving average VanEck Vectors is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VanEck Vectors
by adding it to a well-diversified
Compared to the overall equity markets, risk-adjusted returns on investments in VanEck Vectors Biotech ETF are ranked lower than 7 (%) of all global equities and portfolios over the last 30 days.
|Fifty Two Week Low||103.25|
|Fifty Two Week High||136.84|